CA2609244A1 - Vaccine compositions and methods for the treatment of urinary incontinence - Google Patents

Vaccine compositions and methods for the treatment of urinary incontinence Download PDF

Info

Publication number
CA2609244A1
CA2609244A1 CA002609244A CA2609244A CA2609244A1 CA 2609244 A1 CA2609244 A1 CA 2609244A1 CA 002609244 A CA002609244 A CA 002609244A CA 2609244 A CA2609244 A CA 2609244A CA 2609244 A1 CA2609244 A1 CA 2609244A1
Authority
CA
Canada
Prior art keywords
lhrh
vaccine
mammal
urinary incontinence
female
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002609244A
Other languages
English (en)
French (fr)
Inventor
Syed Ziauddin Hashmi
Bradley John Nettleton
John Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc.
Syed Ziauddin Hashmi
Bradley John Nettleton
John Walker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc., Syed Ziauddin Hashmi, Bradley John Nettleton, John Walker filed Critical Pfizer Products Inc.
Publication of CA2609244A1 publication Critical patent/CA2609244A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA002609244A 2005-06-01 2006-05-22 Vaccine compositions and methods for the treatment of urinary incontinence Abandoned CA2609244A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68678905P 2005-06-01 2005-06-01
US60/686,789 2005-06-01
PCT/IB2006/001398 WO2006129162A2 (en) 2005-06-01 2006-05-22 Vaccine compositions and methods for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
CA2609244A1 true CA2609244A1 (en) 2006-12-07

Family

ID=37072557

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002609244A Abandoned CA2609244A1 (en) 2005-06-01 2006-05-22 Vaccine compositions and methods for the treatment of urinary incontinence

Country Status (15)

Country Link
EP (1) EP1890725A2 (ja)
JP (2) JP2008545738A (ja)
KR (1) KR20080007648A (ja)
CN (1) CN101189026A (ja)
AR (1) AR054370A1 (ja)
AU (1) AU2006253914A1 (ja)
BR (1) BRPI0611390A2 (ja)
CA (1) CA2609244A1 (ja)
MX (1) MX2007015151A (ja)
NO (1) NO20075923L (ja)
RU (1) RU2007143992A (ja)
TW (1) TW200716164A (ja)
UY (1) UY29574A1 (ja)
WO (1) WO2006129162A2 (ja)
ZA (1) ZA200710213B (ja)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3795914B2 (ja) * 1993-04-27 2006-07-12 ユナイテッド・バイオメディカル・インコーポレイテッド ワクチン用免疫原性ｌｈｒｈペプチド構築体および合成普遍免疫刺激器
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) * 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
KR100955668B1 (ko) * 1999-02-05 2010-05-06 더 유니버시티 오브 멜버른 Ｔ 헬퍼 세포 에피토프
CA2427731A1 (en) * 2000-10-30 2002-05-10 University Of Zurich Gnrh analogues for treatment of urinary incontinence
US20030144203A1 (en) * 2001-12-19 2003-07-31 Voyager Pharmaceutical Corporation Methods for slowing senescence and treating and preventing diseases associated with senescence

Also Published As

Publication number Publication date
TW200716164A (en) 2007-05-01
WO2006129162A2 (en) 2006-12-07
ZA200710213B (en) 2008-09-25
CN101189026A (zh) 2008-05-28
EP1890725A2 (en) 2008-02-27
WO2006129162A3 (en) 2007-02-08
RU2007143992A (ru) 2009-07-20
MX2007015151A (es) 2008-02-15
AU2006253914A1 (en) 2006-12-07
UY29574A1 (es) 2006-12-29
JP2009137972A (ja) 2009-06-25
AR054370A1 (es) 2007-06-20
KR20080007648A (ko) 2008-01-22
BRPI0611390A2 (pt) 2010-09-08
JP2008545738A (ja) 2008-12-18
NO20075923L (no) 2007-12-18

Similar Documents

Publication Publication Date Title
EP1140165B1 (en) Improved saponin adjuvant compositions and methods relating thereto
US8741303B2 (en) Immunogenic LHRH compositions and methods relating thereto
US20110142901A1 (en) Sustained release composition
EP2335736B1 (en) Pharmaceutical composition utilising combinations of variants of the gonadotropin-releasing hormone (gnrh) as immunogen
Talwar et al. Anti-fertility vaccines
CA2609244A1 (en) Vaccine compositions and methods for the treatment of urinary incontinence
Turkstra et al. Active immunisation against gonadotropin-releasing hormone, an active tool to block the fertility axis in mammals
CN107174589B (zh) 氢氧化铝在制备防治肝纤维化药物中的应用
WO2001034192A9 (en) Improved method of immunization
June Immunogenic LHRH compositions and methods relating thereto
JPH05501858A (ja) Ｓｒｉｆ関連ペプチドおよびそれらの使用

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued